Mrs. VEENA AHUJA Reference: Dr.DR.

SELF VID: 230176500008523

PIMPARI Haveli Sample Collected At: Registered On:
Tel No : 8552920099 Apsc-Ra-Ishwar Bapurao Thombare
11/04/2023 08:33 AM
S. No. 169 To 173, Mhada Constructed
PIN No: 411018 And Alloted Gala No. 540 / 3088, Sant Collected On:
PID NO: P18323509650081 Tukaram Nagar, Near Y.C.M. Hospital, 11/04/2023 8:18AM
Age: 45 Year(s) Sex: Female Pimpri, Pune - 411018 Reported On:
Processing Location:- Metropolis
Healthcare Ltd. Bhandarkar Road, Pune - 11/04/2023 06:16 PM
411004

Investigation Observed Value Unit Biological Reference Interval

HAV-IgM Ab to Hepatitis A Virus Non Reactive,0.34 S/CO ratio Non Reactive: < 0.8
(Serum,CMIA) Grayzone: 0.8-1.2
Reactive: > 1.2
Interpretation:

This assay detects the presence of hepatitis A virus (HAV)- specific IgM antibody in serum. Non-Reactive results indicate either 1)
inadequate or delayed anti-HAV IgM response after known exposure to HAV, or 2) absence of acute or recent hepatitis A. Grayzone
results may be seen in early acute hepatitis A associated with rising anti-HAV IgM levels or recent hepatitis A infection associated
with declining anti-HAV IgM levels. Retesting for both anti-HAV IgM (HAVM / Hepatitis A IgM Antibody, Serum) and anti-HAV IgG
(HAIGG / Hepatitis A IgG Antibody, Serum ) in 2 to 4 weeks is recommended to determine the definitive HA V infection status.
Reactive results indicate acute or recent (<6 month s) hepatitis A infection.

Anti HEV-IgM Negative,0.77 Index Negative: < 1.0

(Serum,EIA) Equivocal: 1.0-1.2
Positive: > 1.2

Interpretation:

(Positive results confirm the presence of acute or recent (in the preceding 6 months) hepatitis E infection. Negative results indicate
absence of acute or recent hepatitis E infection. Equivocal results may be seen in: 1) acute hepatitis E infection with rising level of
anti- hepatitis E virus (HEV) IgM; 2) recent hepatitis E infection with declining level of anti-HEV IgM; 3) acute hepatitis E infection
with declining level of anti-HEV IgM; 3) acute hepatitis E infection due to HEV genotype 2 strains ; or 4) cross-reactivity with
nonspecific antibodies (i.e. false positive results). Repeat testing of serum for anti -HEV IgM and anti-HEV IgG in 4 to 6 weeks is
recommended to determine the definitive HEV infection status.

-- End of Report --

Tests marked with NABL symbol are accredited by NABL vide Certificate no MC_2034

Page 1 of 1 Dr. Priya Kendre

M.D. Pathology